Guidance for Insulin Pump (CSII) use in hospital. Information for staff Diabetic Care

Similar documents
National Best Practice Guides: Inpatients on Continuous Subcutaneous Insulin Infusion (CSII)

Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation

Continuous Subcutaneous Insulin Infusion (CSII) pump therapy

Diabetes, Ketone testing in Type 1 Diabetes

Pump Failure Guidelines

Peri-Operative Guidelines for Management of Diabetes Patients

Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline

The principles of insulin adjustment guidance

Guideline on Sick day rules for children and young people with diabetes on insulin

Peri-operative management of the surgical patient with diabetes GL059

Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013

Staying safe on an insulin pump

Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Staff at the Nottingham Children s Hospital. Guidelines process.

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

East of England Paediatric Diabetes Network

East of England Children & Young People s (CYP) Diabetes Network

Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016

RELEASED. first steps. Icon Icon name What it means

WHEN YOUR PANCREAS IS NOT A HAPPY CAMPER A PRESENTATION ON DIABETES MANAGEMENT IN THE CAMP SETTING AMANDA COSCHI, BSCN, RN, CDE

DIABETES MANAGEMENT PLAN 2019

A I Page 1 of 10. SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH. Clinical Protocol

Diabetes Newly Diagnosed with NO evidence of DKA

National Diabetes Inpatient Audit (NaDIA) 2016

Lynda Astbury Lead Diabetes Specialist Nurse

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

2016 Diabetes Management Plan

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

DIABETES MANAGEMENT PLAN 2017

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

[Insert School Logo] School Grade Teacher Physician Phone Fax Diabetes Educator Phone 504 Plan on file Yes No

Provincial Clinical Knowledge Topic Insulin Pump Therapy, Pediatric and Adult Acute Care V 1.0

Sick day rules. associated with insulin dependent diabetes. Information for children and young people. Women and Children Paediatrics

SARASOTA MEMORIAL HOSPITAL

DIABETES MANAGEMENT PLAN 2018

Management of adults with diabetes undergoing surgery and elective procedures: Improving standards

Blood Glucose monitoring during extra-corporeal renal therapy and plasmapheresis.

MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY

Colonoscopy and Flexible Sigmoidoscopy advice for Diabetics

PERIOPERATIVE DIABETES GUIDELINE

Self-assessment checklist

2016 Diabetes Management Plan for school Insulin pump therapy [to be used in conjunction with Action Plan]

Supplemental Health Record and Authorization for Care of Child with Insulin Dependent Diabetes

CLINICAL GUIDELINE: Guidelines for managing continuous subcutaneous insulin infusion (CSII, or insulin pump ) therapy in hospitalised patients

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

University College Hospital. Blood glucose and HbA 1 c targets

Updated August /08/2020

Information leaflet for MDI patients. Improving Diabetes using Diasend

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins

Developing a pathway of. and care planning for people with diabetes

Case Study: Competitive exercise

Information for Patients

Virginia Diabetes Medical Management Plan (DMMP)

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people

DIABETES MANAGEMENT PLAN 2017

Insulin Management. By Susan Henry Diabetes Specialist Nurse

Pump Basics for the School Nurse. Children's Endocrinology Center of Dallas

Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham

Placename CCG. Policies for the Commissioning of Healthcare

Pump Mechanics and Management. Basic procedures for initiating pump therapy

Date of birth: Type 2 Other: Parent/guardian 1: Address: Telephone: Home: Work: Cell: address: Camper physician / health care provider:

Injectable Therapies in Diabetes

Northumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE

Diabetes Medical Management Plan

Children & Young People Travelling with Type 1 Diabetes

What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?

Diabetes Medical Management Plan

Title Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)

Insulin Pump An information session to help you decide if you are ready to use an insulin pump.

24 Hour Support. Telephone Available 24 hours a day, 7 days a week

Trust Guideline for the Management of: Insulin Pump Therapy in Children with Type 1 Diabetes

Injectable Therapies in Diabetes

My Sick Day Plan for Type 1 Diabetes on Multiple Daily Injections (MDI)

DIABETES MANAGEMENT PLAN 2018

Current Status: Retired PolicyStat ID: Effective: 03/2017 Approved: 03/2017 Last Revised: 03/2017 Expiration: 03/2020

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group

Diabetes Update and DKA Queensland Paediatric Society of QLD Dr. Jason Yates Paediatric Endocrinologist

Mellitus undergoing Surgery

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

Diabetes Medical Management Plan

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE

Diabetes Labour guideline (GL820)

Diabetes Medical Management Plan

TYPE 1 DIABETES AND EXERCISE. Mark W Savage

Diabetes Medical Management Plan

SCHOOL HEALTH PLAN: DIABETES

9-A. Diabetes Medical Management Plan

TRAVELLING ndss.com.au AND TYPE 1 DIABETES

SFHDiabPT03 Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy

East of England Children & Young People s (CYP) Diabetes Network

Diabetes Medical Management Plan

Transcription:

Guidance for Insulin Pump (CSII) use in hospital Information for staff Diabetic Care

Refer all Insulin Pump patients to the Hospital Diabetes team as soon as possible after admission: Uniersity Hospital Monklands - 01236 712430 DSN or pager 260 or contact Diabetes Consultant ia ward 14 Uniersity Hospital Wishaw - 01698 366361 or DECT 8593 Uniersity Hospital Hairmyres - 01355 584116 DSn or Diabetes Consultant as per Endocrine rota At Weekends all Insulin Pump patients MUST hae daily reiew Insulin pump daily reiew checklist chart This chart should be completed by junior medical staff, nurse practitioners or senior ward nurses e.g. nurse in charge EVERY DAY and used alongside these guidance notes. It is a simple checklist to document if patients are safe to self manage their insulin pump in hospital. In the eent the chart flags any No answers, medical reiew is needed. The Checklist chart is stocked on diabetes wards, medical admissions for printable from NHS Lanarkshire s Diabetes Clinical Guideline site. 2 Guidance for Insulin Pump (CSII) use in hospital

General information about insulin Pumps Continuous Subcutaneous Insulin Infusion (CSII) or insulin pump therapy is administered ia a battery drien pump. Rapid acting insulin (e.g. Noorapid, Humalog, Apidra) is deliered by pump ia an infusion set which is inserted into the subcutaneous tissue. The infusion set should be changed eery 2-3 days. The background (basal) rate at which the insulin is pumped can be pre-programmed to proide a number of different rates across a 24 hour period. These can be adjusted in response to current needs, e.g. during fasting, lifestyle change, illness. Bolus insulin doses are calculated according to carbohydrate food intake (e.g. 1 unit per 10g CHO) and administered by pressing a button on the pump. Regular blood glucose monitoring is essential to guide with insulin dosing. Ketone monitoring is essential in illness, omiting and/or hyperglycaemia (see below) Ensure that all patients using CSII hae sufficient spare consumables e.g. spare batteries and infusion sets (i.e. reseroirs, lines and cannulae). If not, ask a relatie to bring these in the same day. All insulin pump patients hae an alternatie insulin pen MDI (basal bolus) regime for use in case of insulin pump failure or inability to self-manage e.g. during serious illness. Please record this alternatie regimen on Page 2 of Insulin Pump Daily Reiew Checklist Insulin pumps should not be immersed in water. Guidance for Insulin Pump (CSII) use in hospital 3

Neer disconnect the insulin pump unless an alternatie subcutaneous insulin regime or IV insulin infusion therapy has been prescribed and administered to the patient. Remoe the pump 30 minutes after alternatie insulin is gien either subcutaneously or intraenously. Patients receiing CSII therapy in the community are experts in their own management. Once admitted to hospital - LET THEM MANAGE THEIR OWN PUMP. Howeer in some situations this is not safe or appropriate - see Pump Safety Points section. 3 Guidance for Insulin Pump (CSII) use in hospital

Pump safety points Hyperglycaemia If blood glucose leels rise aboe 14 mmol/l, there is a risk of Diabetic Ketoacidosis (DKA). Blood ketones MUST be measured to guide additional sick day doses of rapid acting insulin by patients. If ketones persist at > 1.5 mmol/l for 4 hours, request reiew by MEDICAL TEAM / HECT and send laboratory glucose and U+Es to confirm/exclude DKA. Start IV actrapid and fluids as per DKA protocol. If laboratory results indicate decompensated diabetes rather than DKA, adjust the IV insulin to a ariable rate infusion ( sliding scale ). Insulin pump patients should change their infusion set, line and reseroir eery 2 to 3 days. In the eent of a high blood glucose result with ketones, the patient should be reminded to do an infusion set, line and reseroir change. Hypoglycaemia Treat hypoglycaemia with 15-20g glucose as per HYPOBOX adice, remembering to retest glucose after 15 minutes to ensure resolution There is no need to remoe or suspend the pump if a hypo occurs Once hypoglycaemia is resoled, look for underlying cause and reiew the pump regimen. Guidance for Insulin Pump (CSII) use in hospital 4

CSII pumps in acute illness Use of CSII is NOT recommended in situations where self management is UNSAFE as follows: Acute illness preenting self management, including delirium or unconscious states Diabetic ketoacidosis (DKA) follow the hospital DKA protocol. Prolonged fast peri-operatiely for major surgery inoling general or spinal anaesthetic If the patient does not hae sufficient consumable supplies for pump use in hospital. Patient choice patients may prefer to reert to MDI (basal bolus regime) temporarily in hospital if they don t feel up to pump self management which can be demanding during intercurrent illness as they may not hae their usual family support on hand. In these situations an alternatie insulin regime (subcutaneous or IV) is required. Remoe the CSII infusion set from the subcutaneous site and store the insulin pump in a safe and secure place. 5 Guidance for Insulin Pump (CSII) use in hospital

CSII Pumps and Radiology Procedures X-ray procedures, CT and MRI scanners can interfere with the pump operation, therefore CSII should be remoed prior to and during these. If the procedure is planned to take more than one hour then proide subcutaneous short acting insulin (e.g. Noorapid) to reduce the risk associated with insulin omission. ALWAYS commence IV or administer subcutaneous insulin before disconnecting CSII pump. Allow CSII to run for 30 60 minutes after a subcutaneous insulin injection After an IV infusion has been used, allow CSII and IV infusion to run concurrently for 60 minutes before discontinuing the IV insulin infusion. Remoe the CSII infusion set and store the insulin pump in a safe and secure place. Guidance for Insulin Pump (CSII) use in hospital 6

Prescribing insulin for insulin pump inpatients 1. Drug kardex Prescribe the insulin used in pump reseroir on the RED parenteral section of the drug kardex Write insulin name in BLOCK CAPITALS, route s/cut, dose As Per Chart (APC) and indicate in time section it is a continuous infusion. Insulin pumps use rapid acting insulin i.e. NOVORAPID or HUMALOG A 10 ml insulin ial (NOT penfills) are required for insulin pump reseroir filling 2. Subcutaneous Insulin Chart On page 1 - complete the usual daily insulin as CSII or insulin pump with the name of insulin in pump reseroir (same as prescribed on Drug Kardex). On page 1 also record the aerage daily insulin dose (Total Daily Dose) taken in the preceding 2-3 days. Do not include the current day as that record will be an incomplete 24 hour period. This is found for Medtronic Veo pump in Utilities Menu, TDD and for Medtronic 640G pump - in History Summary menu, TDD and Animas pump in History Menu, Daily Totals On page 1 also record the current daily Basal Insulin dose. This is found for Medtronic Veo pumps in Basal reiew menu, for Medtronic 640G pumps in History Summary menu, and for Animas Vibe pumps in History menu and Daily Totals. Remember the patient is expert and should be able to assist with proiding all this information 7 Guidance for Insulin Pump (CSII) use in hospital

Glucose and ketone monitoring of insulin Pump: inpatient safety It is essential during in-patient periods that ward staff monitor and record finger prick blood glucose leels. Use standard ward blood glucose meters to test patients at least four times daily during waking hours Pre-breakfast, pre-lunch, pre-eening meal and 22:00 are standard times but also check once oernight. Record finger prick blood glucose results on page 3 of the subcutaneous insulin chart. Patient self managing with their pump should monitor their blood glucose leels more frequently than this during illness, usually 7-10 times daily. Patients should hae their own meter and test strips or will request additional tests from ward staff. Patients should enter all blood glucose results into their pump. All pump patients should hae their own blood ketone meter to monitor ketones if blood glucose is aboe 14 mmol/l. Guidance for Insulin Pump (CSII) use in hospital 8

Documenting sick day dose insulin pen deice for pump inpatients If patients using insulin pump deices deelop hyperglycaemia with significant blood ketones (>1.5 mmol/l) they require to take their calculated Sick Day Rule Correctie Insulin Dose (NOVORAPID or HUMALOG pen deice) immediately and then look into cause e.g. insulin pump failure. 1. Drug Kardex Prescribe the rapid acting insulin pen deice used by patient (NOVORAPID Flexpen or HUMALOG Kwikpen) in the As Required section of the Drug Kardex and under dose document Sick Day Rules (SDR) and frequency Maximum eery 2 hours. 2. Subcutaneous Insulin Chart Patient s requiring Sick Day Rule pen insulin should alert ward nursing staff to document dose taken on subcutaneous chart page 2, in comments section, which MUST be a trigger for medical reiew. 9 Guidance for Insulin Pump (CSII) use in hospital

Guidance for Insulin Pump (CSII) use in hospital 10

Pub. date: June 2018 Reiew date: December 2020 Issue No: 01 PIL.INSPMP.18_00702.L 18_20232 Design - Medical Illustration, NHS Lanarkshire